Response NPLS (175 mg/m2) N(%) NPLS (80 mg/m2) N (%) Taxol® (175 mg/m2) N(%)
Complete Response 3 (6.8) 0 0
Partial Response 13 (29.6) 20 (46.5) 5 (20.8)
Overall Response Rate 16 (36.4) 20 (46.5) 5 (20.8)
Stable Disease 22 (50) 18 (41.9) 15 (62.5)
Disease Control Rate 38 ( 86.4) 38 (88.4) 20 (83.3)
* 111 patients qualified for per protocol population for efficacy analysis.
Table 3: Response to Nanosomal Paclitaxel Lipid Suspension (NPLS) or Taxol® (n=111)*.